FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3217318836> ?p ?o ?g. }

• W3217318836 endingPage "279" @default.
• W3217318836 startingPage "268" @default.
• W3217318836 abstract "In the ACOSOG Z0011 trial, patients with primary breast cancer and 1-2 tumor-involved sentinel lymph nodes (SLNs) undergoing breast-conserving surgery had no oncological outcome benefit after axillary lymph node dissection (ALND), despite a relevant rate of non-SLN metastases of 27%. According to the St Gallen expert consensus, and NCCN and ASCO clinical guidelines, ALND may be avoided in patients who meet all ACOSOG Z0011 inclusion criteria. This recommendation can also be extended to patients undergoing mastectomy, with 1 or 2 positive SLNs and an indication for chest wall radiation, in whom axillary radiotherapy can be proposed as an alternative to completion ALND. The aim of this study was to assess non-compliance with the NCCN and ASCO clinical guidelines and Z0011 criteria, namely the rate of performance of completion ALND when it was not recommended, and the rate of failure to perform completion ALND when recommended.Data were prospectively analysed from T1-2 N0 breast cancer patients undergoing an SLN procedure and treated at the Georges-François Leclerc Cancer Center between November 2015 and May 2017. Factors associated with non-compliance treatment decisions were identified using logistic regression.Among 563 patients included, 122 (21.7%) had at least one positive SLN. ALND was not recommended for 76 patients (62.3%), and was recommended in 46 patients (37.7%). The rate of non-compliant treatment was 32% (39/122) overall: ALND was performed despite not being recommended in 16/76 patients (21.1%) and was not performed in 50% of patients in whom it was recommended (23/46). By multivariate analyses, lymphovascular invasion ((Odds Ratio (OR)=6.1; 95% confidence interval (CI): 1.4-26.7; P=0.02)) and only one SLN removed (OR=9.1; 95%CI: 2.2-33.3; P=0.002) were associated with performance of completion ALND when not recommended. Conversely, >1 SLN removed (OR=5.1; 95%CI: 1.2-22.2; P=0.03) was associated with the failure to perform completion ALND when recommended.Almost one third of patients with invasive breast cancer receive treatment that is not in compliance with recommendations regarding completion ALND." @default.
• W3217318836 created "2021-12-06" @default.
• W3217318836 creator A5022884705 @default.
• W3217318836 creator A5027838150 @default.
• W3217318836 creator A5034951520 @default.
• W3217318836 creator A5035439475 @default.
• W3217318836 creator A5037621380 @default.
• W3217318836 creator A5046739456 @default.
• W3217318836 creator A5050912443 @default.
• W3217318836 creator A5056462028 @default.
• W3217318836 creator A5059810021 @default.
• W3217318836 creator A5061565762 @default.
• W3217318836 creator A5071105216 @default.
• W3217318836 creator A5071480204 @default.
• W3217318836 creator A5078065507 @default.
• W3217318836 creator A5084565824 @default.
• W3217318836 creator A5087668765 @default.
• W3217318836 date "2022-03-01" @default.
• W3217318836 modified "2023-10-13" @default.
• W3217318836 title "Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort" @default.
• W3217318836 cites W1504163888 @default.
• W3217318836 cites W1535152873 @default.
• W3217318836 cites W1770259999 @default.
• W3217318836 cites W1881707187 @default.
• W3217318836 cites W1979330539 @default.
• W3217318836 cites W2031047702 @default.
• W3217318836 cites W2042669906 @default.
• W3217318836 cites W2046923877 @default.
• W3217318836 cites W2071616999 @default.
• W3217318836 cites W2088814217 @default.
• W3217318836 cites W2114794378 @default.
• W3217318836 cites W2115527491 @default.
• W3217318836 cites W2131719808 @default.
• W3217318836 cites W2133865595 @default.
• W3217318836 cites W2135084486 @default.
• W3217318836 cites W2136878912 @default.
• W3217318836 cites W2145641730 @default.
• W3217318836 cites W2154806076 @default.
• W3217318836 cites W2164776774 @default.
• W3217318836 cites W2173858545 @default.
• W3217318836 cites W2336254290 @default.
• W3217318836 cites W2336794604 @default.
• W3217318836 cites W2528355750 @default.
• W3217318836 cites W2579017745 @default.
• W3217318836 cites W2754855139 @default.
• W3217318836 cites W2888114015 @default.
• W3217318836 cites W2897417937 @default.
• W3217318836 cites W2989126633 @default.
• W3217318836 cites W993406450 @default.
• W3217318836 doi "https://doi.org/10.1016/j.bulcan.2021.09.018" @default.
• W3217318836 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34838310" @default.
• W3217318836 hasPublicationYear "2022" @default.
• W3217318836 type Work @default.
• W3217318836 sameAs 3217318836 @default.
• W3217318836 citedByCount "2" @default.
• W3217318836 countsByYear W32173188362023 @default.
• W3217318836 crossrefType "journal-article" @default.
• W3217318836 hasAuthorship W3217318836A5022884705 @default.
• W3217318836 hasAuthorship W3217318836A5027838150 @default.
• W3217318836 hasAuthorship W3217318836A5034951520 @default.
• W3217318836 hasAuthorship W3217318836A5035439475 @default.
• W3217318836 hasAuthorship W3217318836A5037621380 @default.
• W3217318836 hasAuthorship W3217318836A5046739456 @default.
• W3217318836 hasAuthorship W3217318836A5050912443 @default.
• W3217318836 hasAuthorship W3217318836A5056462028 @default.
• W3217318836 hasAuthorship W3217318836A5059810021 @default.
• W3217318836 hasAuthorship W3217318836A5061565762 @default.
• W3217318836 hasAuthorship W3217318836A5071105216 @default.
• W3217318836 hasAuthorship W3217318836A5071480204 @default.
• W3217318836 hasAuthorship W3217318836A5078065507 @default.
• W3217318836 hasAuthorship W3217318836A5084565824 @default.
• W3217318836 hasAuthorship W3217318836A5087668765 @default.
• W3217318836 hasConcept C121608353 @default.
• W3217318836 hasConcept C126322002 @default.
• W3217318836 hasConcept C141071460 @default.
• W3217318836 hasConcept C2777757722 @default.
• W3217318836 hasConcept C2780212769 @default.
• W3217318836 hasConcept C2781467025 @default.
• W3217318836 hasConcept C2908949552 @default.
• W3217318836 hasConcept C530470458 @default.
• W3217318836 hasConcept C61434518 @default.
• W3217318836 hasConcept C71924100 @default.
• W3217318836 hasConceptScore W3217318836C121608353 @default.
• W3217318836 hasConceptScore W3217318836C126322002 @default.
• W3217318836 hasConceptScore W3217318836C141071460 @default.
• W3217318836 hasConceptScore W3217318836C2777757722 @default.
• W3217318836 hasConceptScore W3217318836C2780212769 @default.
• W3217318836 hasConceptScore W3217318836C2781467025 @default.
• W3217318836 hasConceptScore W3217318836C2908949552 @default.
• W3217318836 hasConceptScore W3217318836C530470458 @default.
• W3217318836 hasConceptScore W3217318836C61434518 @default.
• W3217318836 hasConceptScore W3217318836C71924100 @default.
• W3217318836 hasIssue "3" @default.
• W3217318836 hasLocation W32173188361 @default.
• W3217318836 hasLocation W32173188362 @default.
• W3217318836 hasOpenAccess W3217318836 @default.
• W3217318836 hasPrimaryLocation W32173188361 @default.
• W3217318836 hasRelatedWork W1987327643 @default.

• next